Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 85.12M P/E - EPS this Y 42.40% Ern Qtrly Grth -
Income -79.19M Forward P/E -0.79 EPS next Y 37.90% 50D Avg Chg -17.00%
Sales 7.43M PEG - EPS past 5Y - 200D Avg Chg -48.00%
Dividend N/A Price/Book 0.68 EPS next 5Y - 52W High Chg -83.00%
Recommedations 1.90 Quick Ratio 2.41 Shares Outstanding 15.68M 52W Low Chg 10.00%
Insider Own 6.01% ROA -49.31% Shares Float 13.95M Beta 2.11
Inst Own 34.84% ROE -124.08% Shares Shorted/Prior 694.05K/792.64K Price 0.57
Gross Margin 100.00% Profit Margin - Avg. Volume 1,046,314 Target Price 24.30
Oper. Margin -7,406.19% Earnings Date Sep 5 Volume 732,715 Change -2.56%
About Affimed N.V.

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany. The company's lead product candidates include AFM13 that has completed Phase 2 clinical trial for CD30-positive lymphoma, Phase Ib clinical trial for hodgkin lymphoma, and completed Phase IIb clinical study for peripheral T-cell lymphoma; AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers; and AFM28, an innate cell engager (ICE), which is in preclinical development for the treatment acute myeloid. It develops AFM32, an ICE candidate that is in preclinical development for the treatment of solid tumors. It has collaboration with Artiva Biotherapeutics to develop the combination of acimtamig and AlloNK; license and strategic collaboration agreement with Roivant Sciences Ltd. to develop and commercialize novel ICE molecules, including AFM32, in oncology; and strategic collaboration agreement with Genentech for the development of certain product candidates, which includes novel NK cell engager-based immunotherapeutics to treat multiple cancers. The company was formerly known as Affimed Therapeutics B.V. and changed its name to Affimed N.V. in October 2014. Affimed N.V. was founded in 2000 and is headquartered in Mannheim, Germany.

Affimed N.V. News
11/19/24 Is Affimed N.V. (AFMD) the Best German Stock to Buy Now?
11/15/24 Affimed NV (AFMD) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges with ...
11/14/24 Affimed N.V.: Q3 Earnings Snapshot
11/14/24 Affimed Reports Third Quarter 2024 Financial Results & Business Update
11/06/24 Affimed to Report Third Quarter 2024 Financial Results & Corporate Update on November 14, 2024
11/05/24 Ultragenyx (RARE) Reports Q3 Loss, Tops Revenue Estimates
11/05/24 Affimed Announces Acceptance of Three Abstracts at the 2024 ASH Annual Meeting Including an Oral Presentation Underscoring Advancing Clinical Pipeline in Leukemia and Lymphoma
10/24/24 683 Capital Management, LLC Expands Stake in Affimed NV
09/10/24 Affimed to Present at the Cantor Global Healthcare Conference 2024
09/05/24 Affimed N.V.: Q2 Earnings Snapshot
09/05/24 Affimed Reports Second Quarter 2024 Financial Results & Business Update
09/04/24 Affimed Appoints New CEO, Shares Fall on Leadership Change
09/03/24 Affimed Appoints Shawn M. Leland as Chief Executive Officer
08/29/24 Affimed to Report Second Quarter 2024 Financial Results & Corporate Update on September 5, 2024
08/27/24 Oculis Holding AG (OCS) Reports Q2 Loss, Misses Revenue Estimates
07/29/24 Affimed (AFMD) to Report Q2 Earnings: What's in the Cards?
06/14/24 Affimed N.V. (NASDAQ:AFMD) Upgraded by Laidlaw
06/13/24 Affimed N.V. (NASDAQ:AFMD) Q1 2024 Earnings Call Transcript
06/12/24 Affimed Reports First Quarter 2024 Financial Results & Business Update
06/07/24 Vanda (VNDA) Surges 24.2%: Is This an Indication of Further Gains?
AFMD Chatroom

User Image TheTarkioTrader Posted - 8 hours ago

$AFMD lol the kiss of death down 32% since your post has it been a week lol

User Image LagunaRay2 Posted - 11 hours ago

@deathknight Started day of q3 CC - Institutional investors has the real picture while retail were told a fantasy about not doing dilutive financing. $afmd

User Image deathknight Posted - 1 day ago

$AFMD As bleak as this looks like, we are getting a bullish inverse divergence (lower price but higher RSI) and extremely low stochastic today. Seems a bounce is coming. But near term will be painful.

User Image deathknight Posted - 1 day ago

$AFMD We lost 1/3 of value in 5 fxxking days. Can anyone enlighten me the catalyst of this horrific performance?

User Image LagunaRay2 Posted - 2 days ago

$AFMD sure looks like Leland will sell 5 million shares (1/3) of O/S and he doesn't give a crap about pricing. 3+ million shrs to go. 10 days to zero MC at current rate.

User Image ItsAGreatDay Posted - 2 days ago

$AFMD I cannot come up with enough superlatives to describe this most frustrating, disgusting, pathetic, irritating, ridiculous, pitiful, upsetting, miserable, despicable, sorry, distressing stock price. Wow! Down 30% in one week!

User Image deathknight Posted - 2 days ago

$AFMD Not many stock is bottomless, but this one surely is.

User Image deathknight Posted - 2 days ago

$AFMD a new 52 week low. Nice! But no need to buy the dip, tomorrow will be cheaper!!

User Image TheTarkioTrader Posted - 2 days ago

$AFMD what a shocker another one of Dieters jems is still garbage

User Image ItsAGreatDay Posted - 3 days ago

$AFMD Trash!

User Image Mollyhound1 Posted - 3 days ago

$AFMD New 52 week low Yea!!

User Image TheTarkioTrader Posted - 3 days ago

$AFMD what a shocker it’s still garbage

User Image deathknight Posted - 3 days ago

$AFMD Worst performer again. Day after day, weeks after weeks and years after years. No hope what so ever.

User Image ItsAGreatDay Posted - 4 days ago

$AFMD WOE! Mercy! Down 10% today for what reason?

User Image deathknight Posted - 4 days ago

$AFMD pretty sure this is the only stock on my portfolio that drifted deep in the red during the post election euphoria. Guess we are going to 0 after all.

User Image TheTarkioTrader Posted - 1 week ago

$AFMD in other words it’s still garbage… you’ve been posting stuff like this split adjusted since around $220. Would you believe it that’s right Deeter $220

User Image Supplement Posted - 1 week ago

$AFMD Pivot Point 3rd Resistance: $4.16 – This is the next resistance level, where the stock might face more selling pressure. If it breaks above this, it could signify strong bullish sentiment.

User Image dhovekamp42 Posted - 1 week ago

$AFMD upcoming milestones schedule - LuminICE-203: Efficacy update of four cohorts to be presented at ASH 2024. - AFM24-102: ORR and safety data from the EGFRwt cohort to be presented at a Company conference call on December 17, 2024. - AFM28-101: Updated data from the dose escalation to be presented at ASH 2024.

User Image davis8uni Posted - 1 week ago

$AFMD

User Image DonCorleone77 Posted - 1 week ago

$AFMD Affimed reports Q3 EPS *EUR0.94) vs. (EUR1.63) last year Reports Q3 revenue EUR155K vs. EUR1.96M last year. "Our innate cell engager therapies are meeting the critical needs of cancer patients who often come to us after exhausting nearly all other treatment options. The responses we've observed, even in the heavily pre-treated populations, give us tremendous confidence," said CEO Shawn Leland. "With clinical proof of concept established for all our innate cell engagers, the demonstrated activity across both hematological and solid tumors, combined with a strong safety profile, underscores the potential of our platform. We are refining our strategy to focus on clinical priorities and commercial viability, ensuring that our therapies deliver meaningful, long-term impact. I'm also very excited about expanding our efforts to seek collaborations with potential partners who share our vision to drive success for both patients and stakeholders."

User Image Supplement Posted - 1 week ago

$AFMD Looking forward to tomorrow.

User Image Slambucket Posted - 1 week ago

$AFMD - guess my add will finish green anyway ;)

User Image Supplement Posted - 1 week ago

$AFMD Resistance just killing us at 3.90 right now but once we get past that we should be good. 3.97 3-10 Day Moving Average Crossover Stalls 3.90 38.2% Retracement From 13 Week High

User Image Supplement Posted - 1 week ago

$AFMD Well, were on the verge of another earning's call and let's hope for stellar data and good numbers. Something big is brewing for us all.

User Image reez007 Posted - 2 weeks ago

$AFMD $20mm stock offering

User Image Lolobel Posted - 2 weeks ago

$AFMD 👍🏻

User Image Supplement Posted - 2 weeks ago

$AFMD is very #Bullish right now.

User Image Supplement Posted - 2 weeks ago

$TNXP Tonix to col­lab­o­rate with Bilthoven Bi­o­log­i­cals on mpox vac­cine: The sin­gle-dose vac­cine, known as TNX-801, is a “live repli­cat­ing, at­ten­u­at­ed virus vac­cine” in pre­clin­i­cal de­vel­op­ment for mpox and small­pox. It is based on horse­pox, Tonix said. Fi­nan­cials of the deal and tim­ing of hu­man stud­ies weren't dis­closed. $AFMD made significant moves this week and are also finishing up a phase 2 in collaboration with Artiva.

User Image Supplement Posted - 2 weeks ago

$AFMD

User Image Supplement Posted - 2 weeks ago

$AFMD With $AFMD now at $3.95, the momentum continues to show a strong upward trend. Let's analyze the updated indicators and price levels: Key Observations Approaching $4.00 Resistance: The price is nearing the $4.00 mark, which is both a psychological and technical resistance level. Breaking above $4.00 could potentially trigger more buying pressure and interest, as $4.00 often acts as a threshold level for new investors to enter or for existing holders to add positions.

Analyst Ratings
HC Wainwright & Co. Buy Nov 15, 23
Cantor Fitzgerald Overweight Sep 25, 23
Cantor Fitzgerald Overweight Sep 12, 23
Cantor Fitzgerald Overweight Sep 7, 23
Truist Securities Buy Aug 11, 23
HC Wainwright & Co. Buy Aug 11, 23
HC Wainwright & Co. Buy Jun 5, 23
HC Wainwright & Co. Buy May 24, 23
Stifel Hold Mar 24, 23